Biotech news
Americas
Mylan has entered a settlement with Genentech and its parent company, Roche, in relation to patents for cancer drug Herceptin. 15 March 2017
Americas
President Trump’s decision to pull the US out of the Trans-Pacific Partnership trade deal may have particularly pernicious consequences for the pharmaceutical and biotechnology industries, writes Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff. 15 March 2017
Americas
Amgen has said in a brief filed at the US Supreme Court that Sandoz “attempts to undermine” the balance between innovation and consumer interests. 14 March 2017
Americas
Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office. 7 March 2017
Biotech
The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis. 6 March 2017
Pharma
The World Health Organization has published a list of antibiotic-resistant “priority pathogens”, a catalogue of 12 families of bacteria which it claims pose the greatest threat to human health. 28 February 2017
Americas
The US Court of Appeals for the Federal Circuit erred in holding that biosimilar applicants must give 180 days’ pre-marketing notice after an application has been approved by the US Food and Drug Administration, according to the acting solicitor general. 28 February 2017
Pharma
“The Unified Patent Court without Britain is a far less potent idea,” says Nick McDonald, partner of Potter Clarkson. 28 February 2017
Biotech
According to the European Commission, if a biotech company crosses two plants to create a new plant through natural means, the outcome will not be patentable, explains Jane Wainwright of Potter Clarkson in a video interview with LSIPR. 23 February 2017
Biotech
European Council members exchanged views on IP at the Competitiveness Council this week, agreeing that IP is one of the drivers of productivity and economic growth for companies. 22 February 2017